About Us
Brands in Conversation
Academic Connect
Marketing Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Friday, October 9, 2026
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
X
WhatsApp
About Us
Brands in Conversation
Academic Connect
Marketing Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Home
Tags
USFDA
Tag: USFDA
Brands in Conversation
Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.
Passionate in Marketing
-
October 6, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets
Author
-
July 29, 2026
0
Brands in Conversation
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Levothyroxine Sodium Tablets
Author
-
May 22, 2026
0
Brands in Conversation
Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia
Author
-
November 7, 2025
0
Brands in Conversation
Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%
Passionate in Marketing
-
July 13, 2024
0
Brands in Conversation
Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg
Passionate in Marketing
-
June 19, 2024
0